Fennec Pharmaceuticals, Inc. (FENC)
11.74
+0.34
(+2.98%)
USD |
NASDAQ |
Aug 25, 16:00
11.74
0.00 (0.00%)
After-Hours: 16:11
Fennec Pharmaceuticals 1 Year Total Returns (Daily) : 31.64% for Aug. 24, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 24, 2026 | 31.64% |
| August 21, 2026 | 38.19% |
| August 20, 2026 | 40.47% |
| August 19, 2026 | 50.06% |
| August 18, 2026 | 44.76% |
| August 17, 2026 | 41.51% |
| August 14, 2026 | 37.40% |
| August 13, 2026 | 32.38% |
| August 12, 2026 | 28.03% |
| August 11, 2026 | 54.91% |
| August 10, 2026 | 31.33% |
| August 07, 2026 | 43.43% |
| August 06, 2026 | 32.84% |
| August 05, 2026 | 28.76% |
| August 04, 2026 | 21.51% |
| August 03, 2026 | 22.32% |
| July 31, 2026 | 16.99% |
| July 30, 2026 | 17.84% |
| July 29, 2026 | 13.00% |
| July 28, 2026 | 14.78% |
| July 27, 2026 | 18.31% |
| July 24, 2026 | 14.56% |
| July 23, 2026 | 16.27% |
| July 22, 2026 | 20.42% |
| July 21, 2026 | 23.54% |
| Date | Value |
|---|---|
| July 20, 2026 | 17.23% |
| July 17, 2026 | 20.00% |
| July 16, 2026 | 17.04% |
| July 15, 2026 | 21.70% |
| July 14, 2026 | 26.96% |
| July 13, 2026 | 22.44% |
| July 10, 2026 | 16.04% |
| July 09, 2026 | 15.97% |
| July 08, 2026 | 17.82% |
| July 07, 2026 | 23.97% |
| July 06, 2026 | 21.48% |
| July 02, 2026 | 25.29% |
| July 01, 2026 | 24.58% |
| June 30, 2026 | 29.52% |
| June 29, 2026 | 33.70% |
| June 26, 2026 | 33.09% |
| June 25, 2026 | 25.60% |
| June 24, 2026 | 23.08% |
| June 23, 2026 | 27.63% |
| June 22, 2026 | 22.81% |
| June 18, 2026 | 15.27% |
| June 17, 2026 | 16.32% |
| June 16, 2026 | 9.67% |
| June 15, 2026 | 15.89% |
| June 12, 2026 | 8.17% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Abeona Therapeutics, Inc. | -16.18% |
| ACADIA Pharmaceuticals, Inc. | 15.19% |
| Alnylam Pharmaceuticals, Inc. | -48.06% |
| Anika Therapeutics, Inc. | 121.1% |
| Savara, Inc. | 75.95% |